# Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer

> **NCT06209099** · NA · RECRUITING · sponsor: **Peking University Cancer Hospital & Institute** · enrollment: 96 (estimated)

## Conditions studied

- Rectal Cancer

## Interventions

- **PROCEDURE:** Nonoperative Management (NOM)
- **PROCEDURE:** Local Excision (LE)
- **PROCEDURE:** Total Mesorectal Excision (TME)

## Key facts

- **NCT ID:** NCT06209099
- **Lead sponsor:** Peking University Cancer Hospital & Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-17
- **Primary completion:** 2025-09-01
- **Final completion:** 2025-11-01
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2025-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06209099

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06209099, "Organ Preservation First Strategy and Intentional Watch and Wait for MRI Defined Low-risk Rectal Cancer". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06209099. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*